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We previously developed novel liposomal nanobubbles (Bubble liposomes [BL])
that oscillate and collapse in an ultrasound field, generating heat and shock
waves. We aimed to investigate the feasibility of cancer therapy using the combi-
nation of BL and ultrasound. In addition, we investigated the anti-tumor mecha-
nism of this cancer therapy. Colon-26 cells were inoculated into the flank of
BALB ⁄ c mice to induce tumors. After 8 days, BL or saline was intratumorally
injected, followed by transdermal ultrasound exposure of tumor tissue (1 MHz,
0–4 W ⁄ cm2, 2 min). The anti-tumor effects were evaluated by histology (necrosis)
and tumor growth. In vivo cell depletion assays were performed to identify the
immune cells responsible for anti-tumor effects. Tumor temperatures were signifi-
cantly higher when treated with BL + ultrasound than ultrasound alone. Intratu-
moral BL caused extensive tissue necrosis at 3–4 W ⁄ cm2 of ultrasound exposure.
In addition, BL + ultrasound significantly suppressed tumor growth at 2–4 W ⁄
cm2. In vivo depletion of CD8+ T cells (not NK or CD4+ T cells) completely blocked
the effect of BL + ultrasound on tumor growth. These data suggest that CD8+ T
cells play a critical role in tumor growth suppression. Finally, we concluded that
BL + ultrasound, which can prime the anti-tumor cellular immune system, may be
an effective hyperthermia strategy for cancer treatment.
H igh-intensity focused ultrasound (HIFU) is a non-invasivetherapy commonly used to destroy a targeted area without
damaging the surrounding tissue.(1,2) This thermal ablation
therapy has been applied to various diseases, including tumor
ablation in the liver, bladder, uterus and prostate.(3–6) However,
there are some limitations regarding the clinical application of
HIFU for cancer therapy.(7) First, several HIFU exposures are
required to ablate the entire volume because the focal point is
only a few square millimeters. Second, sufficient cooling time
must be allowed between applications to prevent the ablation
of normal tissue surrounding the tumor. Consequently, HIFU
treatments involve multiple long sessions that are uncomfort-
able for the patients.(8) In addition, HIFU is currently not
approved for breast cancer because it causes skin burns around
shallow tumors.(2) Most adverse effects are caused by the high
acoustic intensity of HIFU. However, the use of lower acoustic
power or shorter time exposure would reduce treatment
efficacy.
Recent improvements to ultrasound therapy include combi-
nations of HIFU ⁄non-focused ultrasound with microbubbles,
nanobubbles or nanodroplets.(9–11) These bubbles (and droplets
after phase changing of nanodroplets) oscillate under lower
acoustic power. Thereby, a part of the ultrasound energy is
absorbed and changed to heat. Higher acoustic power may lead
to collapse of bubbles. This phenomenon, known as cavitation,
induces jet streams, heat and the generation of reactive oxygen
species,(12–14) thereby damaging nearby cells. When ultrasound
without a focal point is used to irradiate a tissue, the chemical,
thermal and mechanical effects are mild compared to HIFU.
To enhance these effects with a non-focused ultrasound sys-
tem, the combination of bubbles and non-focused ultrasound
has been studied. Nano-bubbles or micro-bubbles oscillate and
disrupt in an ultrasound field, inducing various effects as men-
tioned above. Generally, these effects can be induced even at
low intensity of ultrasound, which has a very small effect
without bubbles. Therefore, it is thought that for non-focused
ultrasound exposure in the absence of bubbles, there is low
risk of tissue damage. Recently, the combination of bubbles
and ultrasound has been utilized in thrombosis systems(15,16)
and gene ⁄drug delivery systems.(17,18) In the field of thermal
effects, it was reported that intravenous administration of
microbubbles caused a fivefold increase in murine kidney tem-
perature during ultrasound exposure.(10) We recently developed
Bubble liposomes (BL) entrapping perfluoropropane gas
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nanobubbles.(19–22) There are various medical applications for
these small and stable BL, such as contrast imaging agents and
drug and gene delivery.(20,22) Moreover, we reported that intra-
tumoral injection of BL enhances the anti-tumor effect of
HIFU in mice.(23) In the present study, we tested the potential
of intratumoral BL and ultrasound (≤4 W ⁄ cm2) as an effective
cancer therapy with reduced adverse effects. In addition, in
physical cancer therapies such as radiotherapy and photody-
namic therapy, it is suggested that their anti-tumor effects are
associated with priming of the systemic immune system for
cancer cells.(24) Moreover, low-pressure pulsed focused ultra-
sound with microbubbles promoted immune cell infiltra-
tions.(25) Therefore, we hypothesized that the combination of
intratumoral injection of BL and ultrasound would enhance the
anti-tumor effect through a mechanism involving anti-tumor
immune responses. In this study, we also studied the effect of
cellular immunity on the therapeutic efficacy of BL + ultra-
sound.
Materials and Methods
Cells and animals. Murine colon adenocarcinoma Colon-26
cells were purchased from RIKEN Cell Bank. Colon-26 cells
were grown in RPMI-1640 (Wako Pure Chemical Industries,
Osaka, Japan) containing 100 U ⁄mL penicillin (Wako Pure
Chemical Industries) and 100 lg ⁄mL streptomycin (Wako
Pure Chemical Industries) supplemented with 10% heat-inacti-
vated FBS (Life Technologies, Carlsbad, CA, USA). BALB ⁄ c
female mice were obtained from Sankyo Labo Service (Tokyo,
Japan) and used at 6 weeks of age. All of the experimental
procedures were performed in accordance with the Teikyo
University guidelines for the welfare of animals in studies of
experimental neoplasia.
Preparation of the Bubble liposomes. Liposomes composed of
1,2-distearoyl-sn-glycero-phosphatidylcholine (DSPC) (NOF,
Tokyo, Japan) and N-(Carbonyl-methoxypolyethyleneglycol
2000)-1,2- distearoyl-sn-glycero-3-phosphatidylethanolamine
(DSPE-PEG(2k)-OMe) (PEG, Mw = ca. 2000) (NOF) (94:6
[mol ⁄mol]) were prepared by reverse-phase evaporation.(19) In
brief, all reagents (total lipid: 100 lmol) were dissolved in
8 mL of 1:1 (v ⁄v) chloroform ⁄diisopropyl ether. A total of
4 mL of PBS was added, and the mixture was sonicated and
evaporated at 65°C. The organic solvent was completely
removed, and the size of the liposomes was adjusted to
<200 nm using an extruding apparatus (Northern Lipids, Van-
couver, BC, Canada) and sizing filters (pore sizes: 100 and
200 nm [Nuclepore Track-Etch Membrane, Whatman, UK]).
After sizing, the liposomes were sterilized through a 0.45-lm
pore size filter (Millex HV filter unit; Durapore PVDF mem-
brane, Millipore, MA, USA). The diameter of the liposomes
(150–200 nm) was measured by dynamic light scattering
(ELS-800; Otsuka Electronics, Osaka, Japan). The lipid con-
centration was measured with an HPLC system (Hitachi High-
Technologies, Tokyo, Japan) and an Evaporative Light Scatter-
ing Detector (ASTECH, Tokyo, Japan). The BL were prepared
using the liposomes and perfluoropropane (Takachiho Chemi-
cal Industrial, Tokyo, Japan). In brief, 5-mL sterilized vials
(Maruemu, Osaka, Japan) containing 2 mL of liposome sus-
pension (lipid concentration: 1 mg ⁄mL) were filled with per-
fluoropropane, capped and supercharged with 7.5 mL of
perfluoropropane. The vial was placed in a bath-type sonicator
(42 kHz, 100 W; Bransonic 2510J-DTH, Branson Ultrasonics,
Danbury, CT, USA) for 5 min to form BL. The liposomes
were reconstituted by sonication and supercharged with
perfluoropropane in the vial. Perfluoropropane was entrapped
within the lipid micelles, comprising DSPC and DSPE-PEG
(2k)-OMe, to form nanobubbles. The perfluoropropane gas
nanobubbles were encapsulated within the reconstituted lipo-
somes. The mean diameter of these BL was approximately
500 nm.
Ultrasound exposure in vivo. Sonitron 2000V (Nepa Gene,
Chiba, Japan) was utilized as a device for ultrasound exposure
in in vivo experiments. This device generates ultrasound from
a non-focused ultrasound transducer (diameter 12 mm).
Mechanical index (MI) values utilized in our study were
0.147, 0.207, 0.254 and 0.283 for acoustic intensity of 1, 2, 3
and 4 W ⁄ cm2, respectively, in 1 MHz. Root mean squared
averages of sound peak pressure were 0.109, 0.154, 0.188 and
0.217 MPa, respectively. These values were supplied from
Nepa Gene.
Tumor inoculation. BALB ⁄ c mice were subcutaneously inoc-
ulated with Colon-26 tumor cells (1 9 106 cells ⁄mouse) into
the flank. After 8 days, we utilized these mice in this experi-
ment as tumor-bearing mice.
Measurements of tumor temperature. Tumor temperature was
measured with a thermocouple (RIC-410; GRAPHTEC, Kana-
gawa, Japan) and data logger (midi LOGGER; GRAPHTEC).
First, the thermocouple was inserted into the center of the
tumor tissue of anesthetized tumor-bearing mice. Second, a
suspension of BL (0.1 mg ⁄mL, 30 lL ⁄mouse) or saline at
room temperature was intratumorally injected at the upper side
of the thermocouple. Third, ultrasound was transdermally
applied via ultrasonic gel (SONOJELLY; Toshiba Medical
Supply, Tokyo, Japan) and ultrasound (frequency 1 MHz, duty
50%, burst rate 2.0 Hz, intensity 0–4 W ⁄ cm2) was exposed to
the tumor for 2 min. Finally, tumor temperature was recorded
at each time point after ultrasound exposure. Under these
exposure conditions, no damage to skin or tissue surrounding
the tumors was seen.
Histochemical analysis. A suspension of BL (0.1 mg lipid ⁄
mL, 30 lL ⁄mouse or saline was injected into the tumor of
tumor-bearing mice, and ultrasound (frequency 1 MHz, duty
50%, burst rate 2.0 Hz, intensity 0–4 W ⁄ cm2) was transder-
mally applied to the tumor for 2 min. After the mice were
killed, the tumor tissue was dissected, fixed with 10%
formaldehyde for 24 h, embedded in paraffin wax and cut into
10-lm-thick sections. The sections were stained with hematox-
ylin and eosin stain (H&E) to evaluate general morphology
under a light microscope (IX-71, Olympus, Tokyo, Japan).
Anti-tumor effect. A suspension of BL (0.1 mg ⁄mL, 30 lL)
or saline was injected into the tumor and ultrasound (frequency
1 MHz, duty 50%, burst rate 2.0 Hz, intensity 0–4 W ⁄ cm2)
was transdermally applied to the tumor for 2 min via ultra-
sonic gel. The anti-tumor effects were evaluated by measuring
tumor volume using the formula: (major axis 9 minor
axis2) 9 0.5.
In vivo depletion assays. The GK1.5 hybridoma (rat anti-
mouse CD4 mAb) and 53-6.72 hybridoma (rat anti-mouse
CD8 mAb) were purchased from the American Type Culture
Collection (Manassas, VA, USA). BALB ⁄ c nude mice were
injected i.p. with each hybridoma, and the ascites were col-
lected to purify antibodies by protein A column (GE Health-
care Japan, Tokyo, Japan). On day 8 after inoculation of
Colon-26 tumor cells, mice were intratumorally injected with
BL or saline, followed by ultrasound (frequency 1 MHz, duty
50%, burst rate 2.0 Hz, intensity 4 W ⁄ cm2). In addition, mice
received 2 i.p. injections (days 5 and 12) of 100 lL ⁄mouse
anti-mouse CD8 antibody (CD8+ cells) or anti-mouse CD4
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antibody (CD4+ cells). Other mice received 5 i.p. injections of
200 lL ⁄mouse anti-asialoGM1 mAb (Wako Pure Chemical
Industries) (NK cells) on days 5, 6, 7, 8 and 13. Other mice
received isotype IgG (normal rat IgG) as a control for antibody
injection. Tumor volume was monitored in vivo as described
above.
Statistical analysis. All animal groups contained four to six
mice. The data are expressed as mean  SD. The different
groups were compared with non-repeated measures ANOVA and
Dunnett’s test. Statistical significance was set at P < 0.05.
Results
Heat generation in tumor tissue with Bubble liposomes and
ultrasound. In vivo studies were conducted with BALB ⁄ c mice
to test the impact of BL collapse on heat generation in the
tumor during ultrasound exposure. Ten days after subcutaneous
inoculation of Colon 26 tumor cells, the anesthetized animals
were intratumorally injected with BL or saline, followed by
ultrasound exposure. Figure 1a shows that tumor temperature
gradually increased with ultrasound intensity. In contrast,
tumor temperatures were significantly higher in the presence
of intratumoral BL, and the overheating effect increased with
ultrasound intensity. In the treatment of BL and 4 W ⁄ cm2
ultrasound exposures, the tumor temperature gradually
increased and achieved the plateau at approximately 1.5 min.
Finally, this tumor temperature at 2 min with BL + ultrasound
was 6°C higher than with saline + ultrasound (Fig. 1b).
Impact of Bubble liposomes ultrasound-mediated tumor dam-
age. Studies were conducted with BALB ⁄ c mice to test the
impact of BL on tumor damage. Eight days after subcutaneous
inoculation of Colon-26 tumor cells, the anesthetized animals
were intratumorally injected with BL or saline, followed by
ultrasound exposure. Histopathological changes were assessed
by H&E staining (Fig. 2). The tumors were not affected by
the 2-min ultrasound exposure, regardless of ultrasound
intensity. In contrast, the presence of intratumoral BL caused
tissue necrosis starting at 3 W ⁄ cm2, and even more necrosis at
4 W ⁄ cm2.
Bubble liposome enhance the anti-tumor effects of ultrasound
exposure. The overall anti-tumor effect of ultrasound exposure
was determined for 22 days after BALB ⁄ c mice were inocu-
lated with Colon-26 tumor cells. The animals were exposed to
ultrasound or a combination of BL and ultrasound on day
8 after inoculation. We first examined an anti-tumor effect
with ultrasound alone. There was a tendency toward tumor
growth suppression at 1–3 W ⁄ cm2, and a weak anti-tumor
effect with 4 W ⁄ cm2 (P < 0.05; Fig. 3a), suppressing tumor
growth to approximately 70% of the control, a reduction of
30% (Fig. 3c). Second, we examined an effect of intratumoral
injection of BL. In the presence of intratumoral BL, significant
anti-tumor responses were detected, starting with 2 W ⁄ cm2,
and increasing with ultrasound intensity (P < 0.05 and 0.01;
Fig. 3b). At an intensity of 4 W ⁄ cm2, the combination of BL
and ultrasound suppressed tumor growth by approximately
45% compared with control (non-treatment) animals (Fig. 3d).
We also examined the anti-tumor effect by intratumoral BL
injection without ultrasound exposure in another experiment.
On day 21 after intratumoral BL injection, tumor volume (%)
was 109.2  23.8 (mean  SD, n = 5) compared to non-treat-
ment mice, indicating no tumor growth suppression without
ultrasound.
The results in Figure 3a and b are from independent experi-
ments. Tumor volume was measured on similar days after
tumor inoculation, but resulted in different tumor volumes. To
compare the anti-tumor effects between these experiments, the
tumor volumes represented in Figure 3c and d were normal-
ized to control tumors from each experiment.
Immune cells responsible for tumor growth suppression by
Bubble liposomes + ultrasound exposure. The combination of
BL and ultrasound damaged tumors, suggesting that tumor-
associated antigens could be released from the damaged
cells and activate immune cells responsible for tumor




































Fig. 1. Tumor temperature after ultrasound exposure with ⁄ without
BL. BALB ⁄ c mice were inoculated with Colon-26 tumor cells in the
flank. After 10 days, a thermocouple was inserted in the tumor of the
anesthetized mice, followed by intratumoral injection of BL or saline,
and ultrasound (0–4 W ⁄ cm2, 2 min). (a) Tumor temperature was mea-
sured at each time point after ultrasound exposure. (b) The data
shows the temperature in tumor tissue at 2 min after ultrasound
exposure. The data represent the mean  SD (n = 3). **P < 0.01 or
**P < 0.05 for the combination of BL and ultrasound compared with
ultrasound. BL, Bubble liposomes; US, ultrasound.
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ment of immune cells known to play major roles in anti-
tumor cellular immunity: CD4+ T cells, CD8+ T cells and
NK cells (Fig. 4). Depletion of NK cells or CD4+ T cells
did not attenuate the anti-tumor effect of BL + ultrasound
exposure. In contrast, the depletion of CD8+ T cells, or
CD4+ and CD8+ T cells, effectively blocked the anti-tumor
effect of BL + ultrasound. These experiments demonstrate
that CD8+ T cells were the predominant effector cells in
this therapeutic response.
Discussion
Nanobubble collapse in ultrasound fields (i.e. acoustic cavita-
tion) is an extremely rapid process. This phenomenon leads to





1 W/cm2 Non-treatment2 W/cm2 3 W/cm2 4 W/cm2
Ultrasound intensity
mµ
Fig. 2. Histopathology of the tumors after
ultrasound exposure with ⁄ without Bubble
liposomes (BL). BALB ⁄ c mice were inoculated in the
flank with Colon-26 tumor cells. After 8 days, the
tumors were treated with intratumoral BL and
ultrasound (1–4 W ⁄ cm2, 2 min) or ultrasound (0–
4 W ⁄ cm2, 2 min). Paraffin sections of the tumors
were stained with H&E. Necrotic areas (dashed
lines) were observed under a light microscope.
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Fig. 3. Tumor growth suppression by ultrasound exposure with ⁄ without BL. BALB ⁄ c mice were inoculated with Colon-26 tumor cells in the
flank. After 8 days, the tumors were treated with: (a) ultrasound (0–4 W ⁄ cm2, 2 min) or (b) intratumoral BL and ultrasound (1–4 W ⁄ cm2, 2 min).
Percentage of tumor volume in the treatment of (c) ultrasound alone or (d) BL + ultrasound compared to non-treatment group after 22 days of
tumor inoculation. Each point represents the mean  SD (n = 4,5). **P < 0.01 or *P < 0.05 compared to non-treatment mice at each time point.
BL, Bubble liposomes; US, ultrasound.
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localized heating of the bubble interior, which breaks molecu-
lar bonds of the gas and vapor. The heat generation has the
potential to induce necrosis.(26–28) Therefore, bubble collapse
could be an asset for ablative cancer therapies. The present
study demonstrates that the injection of BL into the tumor con-
siderably improves the anti-tumor capacity of ultrasound
exposure.
First, in vivo experiments showed higher tumor temperatures
after treatment with a combination of BL and ultrasound than
with ultrasound alone and the benefit increased with beam
intensity (Fig. 1). Morris et al. report additional temperature
rise because of friction between the thermocouple and the bio-
logical tissue upon ultrasound exposure.(29) In that experiment,
a HIFU system was utilized and the ultrasound intensity
(1.7 MHz, free-field spatial-peak temporal average intensities
40–600 W ⁄ cm2) was much higher than that of our system
(1 MHz, acoustic intensity 1–4 W ⁄ cm2). Therefore, in our
experiment, it is expected that the effect of the friction on tem-
perature rise will be low. In Figure 1, the temperature rise with
the combination of BL and ultrasound exposure was higher
than that in saline + ultrasound exposure. This difference in
temperature should be the result from heat generation due to
cavitation of BL. The intratumoral injection of BL has the
potential to increase treatment effectiveness. The capacity of
BL to generate heat during ultrasound exposure suggests that
BL and ultrasound exposure together may induce necrosis
(Fig. 2). Therefore, we used a tumor mouse model to test the
impact of intratumoral BL on these cell responses. Ultrasound
exposure (1–4 W ⁄ cm2) did not induce noticeable tissue dam-
age, whereas the combination of BL and ultrasound exposure
caused considerable tumor necrosis. These data suggest that
intratumoral injection of BL would improve the anti-tumor
effectiveness of ultrasound exposure primarily through tissue
necrosis.
The applicability of BL and ultrasound exposure to cancer
therapy was tested with regard to the tumor growth rate
(Fig. 3). Ultrasound only suppressed tumor growth at the high-
est intensity of 4 W ⁄ cm2. The mechanism of this tumor
growth suppression is not clear. As shown in Figure 1, temper-
ature in tumor gradually increased with increasing ultrasound
intensity also upon treatment with ultrasound exposure alone.
Therefore, some tumor cells may be damaged. The combina-
tion of BL and ultrasound effectively caused tumor growth
suppression starting at 2 W ⁄ cm2. With BL present, an effect
on the tumor growth could be seen at lower ultrasound intensi-
ties than without BL and at the same ultrasound intensity a lar-
ger effect was achieved with BL. We recently reported that
BL can be used for gene delivery under low intensity ultra-
sound (<1 W ⁄ cm2), without cytotoxicity.(20,22) Therefore, low-
intensity ultrasound would be preferable for safe gene delivery
by BL, whereas higher intensities (2–4 W ⁄ cm2) would be
more efficient in combination with the combination of BL and
ultrasound in cancer therapy. An additional parameter to con-
sider for the anti-tumor effect is BL concentration. We have
not optimized the concentration of BL yet. We think that there
is an optimal concentration, as in gene delivery, for the combi-
nation of BL and ultrasound. At too high a concentration, the
BL attenuated the ultrasound beam, which resulted in insuffi-
cient cavitation being induced for effective gene delivery. In
short, higher concentration of BL disturbs the ultrasound trans-
mission and results in it not being effective in inducing cavita-
tion. Finally, tumor tissue would not be effectively insured
under this condition; we should optimize the concentration of
BL.
The mechanism of tumor growth suppression was investi-
gated by in vivo cell depletion assay because the immune
system was implicated in tumor regression during radiation
therapy.(30) Local radiation stimulated the production of
tumor peptide-reactive IFNc-producing antitumor immune
cells and their trafficking to tumor-draining lymph nodes and
tumors. In addition, clinical studies conducted with cancer
patients reported that HIFU tumor ablation induces the infil-
tration of various lymphocyte subsets, including CD4+ and
CD8+ T cells, as well as NK cells.(31,32) The combination of
BL and ultrasound exposure might induce damage to tumor
cells by making pores in cell membrane with mechanical
effects such as induction of jet stream associated with cavita-
tion of BL and by thermal effect. Therefore, we hypothe-
sized that this combination of BL and ultrasound exposure
may also induce the release of tumor-associated antigens via
the pores of the damaged cells that could prime the anti-
tumor immune system. CD8+ T cell depletion and the combi-
nation of CD4+ and CD8+ T cell depletion completely inhib-
ited BL + ultrasound-mediated tumor growth suppression
(Fig. 4). For these treatment groups, tumor growth was rather
enhanced. The reason for the increased tumor growth was
most likely suppression of the immune system, in a similar
way as seen with immunosuppressive agents. In CD4+ and
CD8+ T cells depleted mice, tumor growth was faster than
in non-treated mice, indicating that T cell depletion acceler-
ated tumor growth. In another report, the same phenomenon
was observed.(33) In contrast, neither CD4+ T cells nor NK
cell depletion dramatically inhibited tumor growth suppres-
sion. These data are consistent with the essential role
Non-treatment 
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No depletion (Control)
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Fig. 4. Identification of the immune cells responsible for tumor
growth suppression after exposure to the combination of BL and
ultrasound. BALB ⁄ c mice were inoculated in the flank with Colon-26
tumor cells. For depletion of CD4+ T cells, CD8+ T cells or NK cells,
different mouse groups received i.p. injections of GK1.5 ascites (anti-
CD4), 53–6.72 ascites (anti-CD8) or anti-asialoGM1, respectively.
Other mice were injected with normal rat IgG as a control for anti-
body injection. After 8 days, the tumors were treated with intratu-
moral BL and ultrasound (4 W ⁄ cm2, 2 min). Tumor volume was
monitored. Each point represents the mean  SD (n = 5,6).
**P < 0.01 or *P < 0.05 compared with mice with complete immune
competent cells (no depletion [control]). BL, Bubble liposomes; US,
ultrasound.
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ascribed to CD8+ T cells in radiation-mediated tumor growth
regression. Furthermore, we showed that this immune
response was subset-specific because CD4+ T cells and NK
cells were not involved in the anti-cancer effect. Altogether,
these data show that the anti-tumor effect in BL + ultrasound
therapy specifically involves CD8+ T cells.
In our combination therapy of BL + ultrasound, tumor tissue
was partially destroyed (Fig. 2). Under this condition, tumor
cells might leak from the primary tissue into the blood flow
and induce metastasis. However, in our case, cellular immune
system, especially CD8+ T cells, has been induced against can-
cer cells. Therefore, we expect that this immune system would
suppress tumor metastasis. HIFU treatment also destroys tumor
tissue and might increase the risk of tumor metastasis due to
leaking of tumor cells into the blood flow. However, Xing
et al. reported that the HIFU treatment did not increase the
risk of distant metastasis.(34) They reported the induction of an
anti-tumor immune response that may be harnessed to improve
the overall effectiveness and quality of cancer therapy. Previ-
ously, we also reported that induction of the cellular immune
system was very important to suppress tumor metastasis.(35)
Therefore, we believe that an induction of immune response is
a significant benefit in ultrasound therapy.
In conclusion, the present study suggests that injection of
BL in combination with low intensity ultrasound may be an
effective cancer therapy. We provide evidence that these con-
ditions stimulate the anti-tumor immune responses necessary
for tumor growth regression.
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